These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6135133)

  • 1. Buspirone: a potential atypical neuroleptic.
    Wood PL; Nair NP; Lal S; Etienne P
    Life Sci; 1983 Jul; 33(3):269-73. PubMed ID: 6135133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function.
    Matthews RT; McMillen BA; Sallis R; Blair D
    J Pharmacol Exp Ther; 1986 Oct; 239(1):124-31. PubMed ID: 2876091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.
    Saller CF; Salama AI
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):125-32. PubMed ID: 2878374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic effects of buspirone, a novel anxiolytic agent.
    Cimino M; Ponzio F; Achilli G; Vantini G; Perego C; Algeri S; Garattini S
    Biochem Pharmacol; 1983 Mar; 32(6):1069-74. PubMed ID: 6838654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs.
    Rupniak NM; Hall MD; Kelly E; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
    J Neural Transm; 1985; 62(3-4):249-66. PubMed ID: 2863324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes.
    Reuss B; Unsicker K
    Mol Cell Neurosci; 2001 Aug; 18(2):197-209. PubMed ID: 11520180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine.
    Pich EM; Samanin R
    Psychopharmacology (Berl); 1986; 89(1):125-30. PubMed ID: 2874581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission.
    McMillen BA
    J Neural Transm; 1985; 64(1):1-12. PubMed ID: 2866230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of risperidone, clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons of the rat brain.
    Bruggeman R; Westerink BH; Timmerman W
    Eur J Pharmacol; 1997 Apr; 324(1):49-56. PubMed ID: 9137912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.
    Chiodo LA; Bunney BS
    J Neurosci; 1983 Aug; 3(8):1607-19. PubMed ID: 6135762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential actions of classical and atypical neuroleptics on mouse nigrostriatal neurons.
    Wood PL; McQuade PS; Etienne P; Lal S; Nair NP
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):765-8. PubMed ID: 6141617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of action of substituted benzamide drugs.
    Köhler C; Ogren SO; Fuxe K
    Acta Psychiatr Scand Suppl; 1984; 311():125-37. PubMed ID: 6142588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of buspirone on rat plasma prolactin levels and striatal dopamine turnover.
    Meltzer HY; Simonovic M; Fang VS; Gudelsky GA
    Psychopharmacology (Berl); 1982; 78(1):49-53. PubMed ID: 6128756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zetidoline, a novel neuroleptic, activates nigral dopaminergic neurons in rats.
    Mereu G; Fanni B; Collu M; Diena A; Glasser A
    Life Sci; 1985 Feb; 36(5):459-64. PubMed ID: 2857469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats.
    See RE; Toga AW; Ellison G
    J Neural Transm Gen Sect; 1990; 82(2):93-109. PubMed ID: 1977417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CI-943, a potential antipsychotic agent. II. Neurochemical effects.
    Pugsley TA; Coughenour LL; Myers SL; Shih YH; Courtland GG; Berghoff W; Stewart SF
    J Pharmacol Exp Ther; 1989 Oct; 251(1):113-22. PubMed ID: 2571713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antipsychotic drugs on the long-term effects of amphetamine on nigro-striatal dopamine neurons in iprindole-treated rats.
    Steranka LR
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):198-204. PubMed ID: 6145099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
    Ogren SO; Hall H; Köhler C; Magnusson O; Lindbom LO; Angeby K; Florvall L
    Eur J Pharmacol; 1984 Jul; 102(3-4):459-74. PubMed ID: 6149133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.